MYNZ - MAINZ BIOMED N.V.

0.83
0.019   2.241%

Share volume: 180,597
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.26%

PREVIOUS CLOSE
CHG
CHG%
$0.81
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
0%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 0%
Performance
5 Days
8.26%
1 Month
-4.07%
3 Months
-23.15%
6 Months
-49.39%
1 Year
-85.20%
2 Year
-11.87%
Key data
Stock price
$0.83
P/E Ratio 
0.00
DAY RANGE
$0.80 - $0.83
EPS 
N/A
52 WEEK RANGE
$0.55 - $5.54
52 WEEK CHANGE
-$83.10
MARKET CAP 
6.210 M
YIELD 
N/A
SHARES OUTSTANDING 
17.557 M
DIVIDEND
$0.00
EX-DIVIDEND DATE
12-03-2024
NEXT EARNINGS DATE
04-29-2025
BETA 
0.26
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$184,104
AVERAGE 30 VOLUME 
$606,113
Company detail
CEO: Guido Baechler
Region: US
Website: mainzbiomed.com
Employees: 30
IPO year: 2021
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Mainz Biomed B.V. develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. The company was founded in 2008 and is based in Mainz, Germany.

Recent news